Abstract / Description of output
Loss of motor function is common after stroke and leads to significant chronic disability. Stem cells are capable of self-renewal and of differentiating into multiple cell types, including neurones, glia, and vascular cells. We assessed the safety of granulocyte-colony-stimulating factor (G-CSF) after stroke and its effect on circulating CD34+ stem cells.
Original language | English |
---|---|
Pages (from-to) | 2979-83 |
Number of pages | 5 |
Journal | Stroke |
Volume | 37 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2006 |
Keywords / Materials (for Non-textual outputs)
- Aged
- Bone Marrow Transplantation
- Brain Ischemia
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Granulocyte Colony Stimulating Factor, Recombinant
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Pilot Projects
- Prospective Studies
- Stroke